Prime Medicine, Inc. (PRME) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q2 EPS of ($0.47), $0.06 worse than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RadNet (RDNT) Tops Q2 EPS by 9c; offers guidance
- Tredegar Corp. (TG) Tops Q2 EPS by 18c
- Avalon Holdings (AWX) Tops Q2 EPS by 23c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
